BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| DR. REDDY'S LAB LTD ADR (NYSE: RDY) | Delayed: 13.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.23 | 52 Week High | $54.73 | |||
| Open | $13.23 | 52 Week Low | $40.68 | |||
| Day High | $13.23 | P/E | N/A | |||
| Day Low | $13.23 | EPS | $0.00 | |||
| Volume | 213 | |||||
